- Home
- ABVC vs COHN Comparison
ABVC vs COHN Comparison
Compare ABVC & COHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- COHN
- Stock Information
- Founded
- ABVC 2015
- COHN 1999
- Country
- ABVC United States
- COHN United States
- Employees
- ABVC N/A
- COHN N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- COHN Investment Bankers/Brokers/Service
- Sector
- ABVC Health Care
- COHN Finance
- Exchange
- ABVC Nasdaq
- COHN Nasdaq
- Market Cap
- ABVC 22.1M
- COHN 17.9M
- IPO Year
- ABVC N/A
- COHN N/A
- Fundamental
- Price
- ABVC $3.39
- COHN $10.49
- Analyst Decision
- ABVC
- COHN
- Analyst Count
- ABVC 0
- COHN 0
- Target Price
- ABVC N/A
- COHN N/A
- AVG Volume (30 Days)
- ABVC 713.8K
- COHN 9.0K
- Earning Date
- ABVC 08-13-2025
- COHN 08-04-2025
- Dividend Yield
- ABVC N/A
- COHN 9.43%
- EPS Growth
- ABVC N/A
- COHN N/A
- EPS
- ABVC N/A
- COHN N/A
- Revenue
- ABVC $508,383.00
- COHN $84,171,000.00
- Revenue This Year
- ABVC $735.18
- COHN N/A
- Revenue Next Year
- ABVC N/A
- COHN N/A
- P/E Ratio
- ABVC N/A
- COHN N/A
- Revenue Growth
- ABVC 1904.43
- COHN N/A
- 52 Week Low
- ABVC $0.40
- COHN $6.10
- 52 Week High
- ABVC $5.48
- COHN $11.52
- Technical
- Relative Strength Index (RSI)
- ABVC 58.50
- COHN 75.42
- Support Level
- ABVC $3.30
- COHN $9.85
- Resistance Level
- ABVC $3.92
- COHN $10.52
- Average True Range (ATR)
- ABVC 0.65
- COHN 0.21
- MACD
- ABVC -0.04
- COHN -0.01
- Stochastic Oscillator
- ABVC 41.57
- COHN 84.41
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About COHN Cohen & Company Inc.
Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.